Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subcutaneous Tumor”

487 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 487 results

Large-scale testing (Phase 3)Study completedNCT05039190
What this trial is testing

Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients

Who this might be right for
Myasthenia Gravis
Harbour BioMed (Guangzhou) Co. Ltd. 132
Not applicableNot Yet RecruitingNCT05879796
What this trial is testing

Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer

Who this might be right for
Cervical Cancer
Peking University Third Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT06055959
What this trial is testing

Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 8
Not applicableLooking for participantsNCT06830759
What this trial is testing

Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma

Who this might be right for
Diffuse Large B-cell LymphomaFollicular Lymphoma
AbbVie 700
Large-scale testing (Phase 3)Study completedNCT01987505
What this trial is testing

MabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Rituximab During First-Line Treatment for Lymphoma

Who this might be right for
Lymphoma, Non Hodgkin
Hoffmann-La Roche 140
Testing effectiveness (Phase 2)Looking for participantsNCT07451912
What this trial is testing

Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AML

Who this might be right for
Acute Myeloid Leukemia (AML)CEBPA MutationUnfit, New-diagnosis AML
The First Affiliated Hospital of Soochow University 29
Large-scale testing (Phase 3)Study completedNCT03493854
What this trial is testing

Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer

Who this might be right for
Early Breast Cancer
Hoffmann-La Roche 500
Large-scale testing (Phase 3)Study completedNCT01926886
What this trial is testing

Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)

Who this might be right for
Breast Cancer
Hoffmann-La Roche 102
Large-scale testing (Phase 3)Study completedNCT00826410
What this trial is testing

Prospective Study on the Value of Subcutaneous Drains in Gastrointestinal Surgery

Who this might be right for
Digestive System Diseases [C06]Digestive System Neoplasms [C04.588.274]
University Hospital Freiburg 200
Testing effectiveness (Phase 2)Study completedNCT00230282
What this trial is testing

Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaB-cell LeukemiaChronic Leukemia+1 more
Steven E. Coutre 25
Early research (Phase 1)Not Yet RecruitingNCT07036185
What this trial is testing

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

Who this might be right for
Gastric/Gastroesophageal Junction CancerBreast CancerColorectal Cancer+3 more
Shanghai Bao Pharmaceuticals Co., Ltd. 66
Large-scale testing (Phase 3)Active Not RecruitingNCT04906395
What this trial is testing

Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer

Who this might be right for
Breast Cancer
Tolmar Inc. 250
Large-scale testing (Phase 3)Study completedNCT04509622
What this trial is testing

Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 14
Large-scale testing (Phase 3)Study completedNCT03211065
What this trial is testing

Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous Ig

Who this might be right for
Secondary Immune Deficiency
Rochester General Hospital 16
Large-scale testing (Phase 3)Study completedNCT00416871
What this trial is testing

Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Centre Leon Berard 220
Not applicableLooking for participantsNCT05978141
What this trial is testing

A Registry for People With T-cell Lymphoma

Who this might be right for
T-cell LymphomaNK-Cell LymphomaT-cell Prolymphocytic Leukemia+28 more
Memorial Sloan Kettering Cancer Center 1,000
Large-scale testing (Phase 3)Study completedNCT00950300
What this trial is testing

Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 596
Large-scale testing (Phase 3)Study completedNCT01542034
What this trial is testing

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Who this might be right for
Moderate or Severe Submental Fullness
Kythera Biopharmaceuticals 506
Early research (Phase 1)Ended earlyNCT03864419
What this trial is testing

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Who this might be right for
Burkitt LymphomaKSHV-associated Multicentric Castleman DiseaseDiffuse Large B-Cell Lymphoma
Fred Hutchinson Cancer Center 18
Large-scale testing (Phase 3)Study completedNCT05297565
What this trial is testing

Compare Nivolumab Administered Subcutaneously vs Intravenous in Melanoma Participants Following Complete Resection

Who this might be right for
Melanoma
Bristol-Myers Squibb 14
Load More Results